Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Search

Redx Reports Encouraging Zamaporvint (RXC004) Phase 2 Combination

EQS-News: JP Jenkins Ltd Redx Reports Encouraging Zamaporvint (RXC004) Phase 2 Combination Data in MSS mCRC at ESMO GI Congress Supporting Genetic Selection Hypothesis in Hard-to-Treat GI Cancers  28-Jun-2024 / 10:39 GMT/BSTThe issuer is solely responsible for the content of this announcement. 28th June 2024ISIN: GB00BSNB6S51JPJ:REDX  REDX PHARMA LIMITED (“Redx” or the “Company”) Redx Reports Encouraging Zamaporvint (RXC004) […]